The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
I’m looking at this share, it’s intriguing given the good trading updates but I don’t know anything about this market sector.
What a people’s realistic expectations of this share in the months ahead? Now that we’re in autumn, Covid levels are up, the economy is no doubt in for some tough months ahead, I’m not sure if it’s worth investing until winter is over.
Bought more at 61.5p = bargain!
MMs moving bid /ask around so all buys look like sells - why would they want to do that? LOL
Good luck all holders ready for next Tuesdays H1 results (which we already know were 30% higher than H1 last year due to the trading update..
A fool and his money are easily parted.
Can't believe someone has sold 10,000 shares at 57.75p. The bid is showing 62p. Surely if you wanted to sell, you would sell in small blocks and get the higher price.
Some people must have money to burn!
Still don't understand why they are selling, unless need funds elsewhere
H1 results due 6th October so not far off and we know they will be good.
Rich the reason it appears unloved is mainly down to size. At a £44m MCAP it too small for most funds to be able to invest. The other side to that coin is that it allows PI like us to get in at a very attractive valuation. We just need to be patient. This company will grow and over the years not only will its increasing profits drive its valuation so will an increased rating. I look at this as a 5 year investment.
Tried some dummy buys today. I can buy £10k shares for 64.55p, so there's got to be a big seller out there still - Premier Miton still reducing stake? Would buy more, but suspect price may slip a bit as no real volume of buyers and as ever, no media coverage. A small, profitable and growing company selling medical equipment during a global pandemic, that no one seems interested in? Why
Agree, good to see that the £5m ventilator order for NHS has been fulfilled and that SLE have delivered £7m orders.
I just can't believe this share is so far under the radar - the volume of shares traded each day is minimal. Just needs some coverage by media - who it seems would rather tip companies with bombed out accounts, doing fundraises rather than a profitable, growing company selling medical equipment during a pandemic - doesn't make any sense to me...
Great to see the NHS ventilator deliveries increasing to a total £7.1m. IHC will continue to benefit from ongoing ventilator support contract orders.
And there's the closing sentence that "The additional revenues from these orders positions the Company very well to achieve a strong performance this financial year."
Https://uk.advfn.com/stock-market/london/inspiration-healthcare-IHC/share-news/Inspiration-Healthcare-Group-PLC-Ventilator-delive/83267138
In case you missed it related earlier announcement: See :-
https://www.bsuh.nhs.uk/revolutionary-technology-trialled-at-brighton-special-care-baby-unit/
Good news on Project Wave:
Https://uk.advfn.com/stock-market/london/inspiration-healthcare-IHC/share-news/Inspiration-Healthcare-Group-PLC-Project-Wave-IRA/83211385
"Neil Campbell, Chief Executive Officer, commented: "We are pleased to have submitted this application and moving the project on to the next phase. The Project WAVE device we have developed incorporates the latest findings in neonatal respiration from a leading U.S. West Coast University with Inspiration Healthcare's experience and knowledge in designing and manufacturing neonatal devices which improve medical outcomes. Once our submission gets the green light, which we expect in a few months, we look forward to working with the team at the Royal Sussex and getting the project one step closer to fruition."
Hello gents,
Genedrive AIHL test due to market in the Autumn, which is technically now onwards.
First test of its kind in the world. Hopefully it’s a success for you guys and us folks in GDR too.
Premier Miton reduce holding by 1.56% hence sale of just over 1m shares yesterday. They still hold16.35% however.
Assume they have finished selling now as declared on a TR1.
Hopefully onwards and upwards..
Delayed buys / sells going through after 1630...….Somethings happening!
250k "sold"? at 67.5p at 163-0 hrs (not U/T)
500k at 67.5p. Looks like Fund Managers making some changes to portfolios??
Someone's got faith in IHC, 350k shares bought at 67.75p (£237.1k buy) Wish I had that sort of cash!
350k buy at 67.75p (£237K) Interesting...
I can't believe there are still some people selling at 66p into the rise. This is a great investment with virtually no risk as I see it. Small, profitable growth company selling medical equipment during pandemic crisis! Hopefully maiden dividend next year.
All it will take is some good media coverage and this will move permanently into the 70ps IMO
Good update again today and lets hope its followed by further updates as the remaining £2m ventilator contract for the NHS is filled.
yes nice positive update.
https://uk.advfn.com/stock-market/london/inspiration-healthcare-IHC/share-news/Inspiration-Healthcare-Group-PLC-Update-on-Ventila/83105733
Very good news all round:
- strong trading continues into H2
- the original NHS order deliveries will further benefit H2
- the second NHS order via the newly acquired SLE is a further bonus I was unaware of?
- further optimism as to the outlook and to acquisition integration
Hello troutisout, had missed the Clinical Services Journal article. Very interesting as the present largely forced air warming must be an unneeded worry worldwide for both Operating Theatre & ICU personnel with the covid bug around.
.....and I suppose even more so, now delayed elective surgeries and the reported 10m backlog, now need to be worked through.
IHC, retweeting this post from 3 months ago, looks like demand is still soaring.
https://www.clinicalservicesjournal.com/story/32782/demand-for-air-free-patient-warming-technology-soars-in-response-to-covid-19
This was in the Genedrive placing RNS, note the projected revenues for this test.
"Antibiotic-Induced Hearing Loss ("AIHL")
Around one in 500 infants carry a genetic mutation that's puts them at risk of suffering lifelong profound hearing loss after exposure to gentamycin, a commonly used antibiotic. genedrive has developed world's first rapid point-of-care genetic test for neonatal intensive care. There are no other point-of-care tests commercially available for AIHL and the Directors believe genedrive's test could support a new standard of care for all urgent case infants.
genedrive's AIHL test has a high clinical accuracy with 100% sensitivity and 100% specificity. Implementation trials for the test are progressing at Manchester and Liverpool but, as announced on 25 March 2020, have not been able to continue at the same pace as previous months as a result of NHS resources being diverted to address COVID-19.
On 24 April 2020, genedrive announced that it had entered into a distribution agreement with Inspiration Healthcare Group plc for the distribution of genedrive's AIHL test in the UK and Ireland. The Directors estimate the UK and global markets for this test to be worth up to £3.5 million and £35 million per year, respectively, to genedrive based on a price of £2,000 per Genedrive® unit and £35 per test."
Safy, I couldn't find it but I am sure there was an interview where it was mentioned that IHC would work towards getting a recommendation from NICE to use the test as gold standard, this would be done in line with the studies ongoing at the moment. I can only think that Genedrive are using IHC as they do have a good network of contacts/distributors that they already sell equipment to, the acquisition of SLE adds even more Global spread, so after the UK and Ireland, the rest of the World beckons....